Julie Anderson
Medical · Westport, NYNPI 1508949009
Payments from drug & device makers
Across 179 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$831
- Novo Nordisk$492
- GSK$442
- Johnson & Johnson$351
- AstraZeneca$319
- Novartis$175
- plus $980 from 11 others
What the payments were for
- Food & beverage$3,44096%
- Education$1504%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $831 |
| Novo Nordisk | 27 | $492 |
| GSK | 21 | $442 |
| Johnson & Johnson | 13 | $351 |
| AstraZeneca | 14 | $319 |
| Novartis | 8 | $175 |
| Astellas Pharma US Inc | 3 | $174 |
| Pfizer | 8 | $164 |
| Otsuka America Pharmaceutical, Inc. | 9 | $150 |
| Lilly USA, LLC | 9 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $114 |
| Amgen | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| Biohaven Pharmaceuticals, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $38 |
| Boehringer Ingelheim | 2 | $33 |
| Abbott | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$117
How this compares
$3,590 in reported general payments places this provider in the 85th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 113 | $149,934 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 98 | $113,678 |
| OzempicSemaglutide | 62 | $69,436 |
| MounjaroTirzepatide | 45 | $58,151 |
| JanuviaSitagliptin Phosphate | 30 | $47,509 |
| RexultiBrexpiprazole | 32 | $46,390 |
| JardianceEmpagliflozin | 34 | $43,054 |
| XareltoRivaroxaban | 33 | $39,146 |
| RybelsusSemaglutide | 25 | $33,699 |
| FarxigaDapagliflozin Propanediol | 25 | $28,587 |
| TrulicityDulaglutide | 22 | $27,021 |
| Breo ElliptaFluticasone/Vilanterol | 36 | $25,727 |
| VraylarCariprazine Hcl | 14 | $19,924 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 19 | $18,063 |
| LinzessLinaclotide | 26 | $16,107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $442 | $151,543145 claims |
| PfizerEliquis | $164 | $149,934113 claims |
| Novo NordiskOzempic, Rybelsus | $492 | $103,13587 claims |
| Lilly USA, LLCMounjaro, Trulicity | $135 | $85,17267 claims |
| AbbVieVraylar, Linzess, Qulipta | $831 | $50,38253 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $33 | $49,44145 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $319 | $46,65044 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $150 | $46,39032 claims |
| Johnson & JohnsonXarelto | $351 | $39,14633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,395 medical providers in New York.
Other medical in Westport
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.